Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 52 clinical trials
Featured trial
Safety & Efficacy Study of Relamorelin in Diabetic Gastroparesis

This trial studies the safety and effectiveness of an experimental drug for diabetic gastroparesis.

  • 83 views
  • 13 Aug, 2019
  • 1 location
Featured trial
The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis.

The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis. 

  • 143 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma (516-003)

This is a study involving an investigational (experimental) drug called sitravatinib, given in combination with the immunotherapy nivolumab (also known as OPDIVO®).  Sitravatinib

tumor cells
platinum-based chemotherapy
advanced urothelial cancer
advanced urothelial carcinoma
carcinoma
  • 86 views
  • 02 Jun, 2021
  • 1 location
IN VIVO AND IN VITRO COMPARATIVE STUDY ON EFFICACY OF ANSA (Experimental Drug) & CRAN MAX (Control Drug) SACHET IN UNCOMPLICATED UTI

I This clinical trial aims to VIVO AND IN VITRO COMPARATIVE STUDY ON EFFICACY OF ANSA (experimental drug) & CRAN MAX (control drug) SACHET IN UNCOMPLICATED UTI in females. The main

Accepts healthy volunteers
  • 0 views
  • 25 Oct, 2022
  • 2 locations
CAR-T Followed by Bispecific Antibodies

The research study is being conducted to test the safety and effectiveness of the experimental drug mosunetuzumab (Cohort 1) or obinutuzumab and glofitamab (Cohort 2) when given after CAR

  • 0 views
  • 04 Oct, 2022
  • 1 location
Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF

day of each cycle randomized 1:1:1 . The dose of the experimental drug MW05 in phase III were determined by independent data monitoring committee (IDMC) according to the efficacy and safety of

  • 0 views
  • 26 Jan, 2021
  • 1 location
Study of IMCY-0141 in Recent Onset of Multiple Sclerosis (IMCY-MS-001)

The IMCY-MS-001 study is a study to test a new experimental drug, IMCY-0141, for the treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS). The pathophysiology of MS with known

  • 0 views
  • 05 Jul, 2022
  • 1 location
A Study of Anti-IL-6R mAb Injection in Patients With iMCD

This study is a single-arm, open-label, multicenter, dose-escalation clinical study.Its primary purpose is to evaluate the safety and tolerability of recombinant humanized anti-interleukin-6 receptor monoclonal antibody ( Anti-IL-6R mAb ) injection in patients with Idiopathic Multicentric Castleman's Disease ( iMCD ) and to determine the recommended dose for follow-up studies. …

  • 0 views
  • 10 May, 2022
  • 1 location
Safety and Effectiveness of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood

Quizartinib is an experimental drug. It is not approved for regular use. It can only be used in medical research. Children or young adults with a certain kind of blood cancer (FLT3-ITD

induction chemotherapy
flt3 internal tandem duplication
consolidation therapy
hematologic malignancy
cancer
  • 61 views
  • 07 Oct, 2022
  • 38 locations
An Open-label, Phase 2 Basket Study of SEA-CD40 Combination Therapies in Advanced Malignancies

This trial is being done to see if an experimental drug (SEA-CD40) works when it's given with other cancer drugs to treat some types of cancer. It will also study side effects from the drug.

progressive disease
lung carcinoma
BRAF
immunologic adjuvant
immunomodulators
  • 0 views
  • 28 Oct, 2022
  • 29 locations